Literature DB >> 3023891

Hepatitis B surface antigen: an unusual secreted protein initially synthesized as a transmembrane polypeptide.

B E Eble, V R Lingappa, D Ganem.   

Abstract

Hepatitis B surface antigen (HBsAg), the major coat protein of hepatitis B virus, is also secreted from cells as a subviral particle, without concomitant cleavage of N-terminal amino acid sequences. We examined this unusual export process in a cell-free system and showed that the initial product of HBsAg biosynthesis is an integral transmembrane protein, with most or all of its C-terminal half on the lumenal side of the endoplasmic reticulum membrane. To study the nature of its topogenic signals, we synthesized fusion proteins between HBsAg and the nonsecreted protein alpha-globin. Fusion proteins in which approximately 100 amino acids of globin preceded all HBsAg sequences were successfully translocated in vitro; the same domain as in the wild-type HBsAg was transported into the vesicle lumen. Fusions in which the entire globin domain was C terminal were able to translocate both the C-terminal region of HBsAg and its attached globin domain. Thus, uncleaved signal sequences in p24s function to direct portions of the molecule across the membrane and are able to perform this function even when positioned in an internal protein domain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023891      PMCID: PMC367670          DOI: 10.1128/mcb.6.5.1454-1463.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Glycosylation of a membrane protein is restricted to the growing polypeptide chain but is not necessary for insertion as a transmembrane protein.

Authors:  J E Rothman; F N Katz; H F Lodish
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

2.  On the hydrophobic part of aminopeptidase and maltases which bind the enzyme to the intestinal brush border membrane.

Authors:  S Maroux; D Louvard
Journal:  Biochim Biophys Acta       Date:  1976-01-21

3.  Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen.

Authors:  D L Peterson; I M Roberts; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

4.  Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes.

Authors:  M A Gerber; S Hadziyannis; C Vissoulis; F Schaffner; F Paronetto; H Popper
Journal:  Am J Pathol       Date:  1974-06       Impact factor: 4.307

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

Review 6.  The virus of hepatitis, type B. (Second of two parts).

Authors:  W S Robinson; L I Lutwick
Journal:  N Engl J Med       Date:  1976-11-25       Impact factor: 91.245

7.  A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

9.  Transfer of proteins across membranes. II. Reconstitution of functional rough microsomes from heterologous components.

Authors:  G Blobel; B Dobberstein
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

10.  Nascent chicken ovalbumin contains the functional equivalent of a signal sequence.

Authors:  V R Lingappa; D Shields; S L Woo; G Blobel
Journal:  J Cell Biol       Date:  1978-11       Impact factor: 10.539

View more
  56 in total

1.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles.

Authors:  K Ueda; T Tsurimoto; K Matsubara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Mutational analysis of hepatitis B surface antigen particle assembly and secretion.

Authors:  V Bruss; D Ganem
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 4.  Intracellular traffic of newly synthesized proteins. Current understanding and future prospects.

Authors:  V R Lingappa
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 5.  Nature and display of hepatitis B virus envelope proteins and the humoral immune response.

Authors:  A Alberti; W H Gerlich; K H Heermann; P Pontisso
Journal:  Springer Semin Immunopathol       Date:  1990

Review 6.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

7.  The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences.

Authors:  B E Eble; V R Lingappa; D Ganem
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.

Authors:  H S Mason; J M Ball; J J Shi; X Jiang; M K Estes; C J Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Domains of the Hepatitis B Virus Small Surface Protein S Mediating Oligomerization.

Authors:  Sascha Suffner; Nadine Gerstenberg; Maria Patra; Paula Ruibal; Ahmed Orabi; Michael Schindler; Volker Bruss
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

10.  Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain.

Authors:  J Le Seyec; P Chouteau; I Cannie; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.